Published in Age Ageing on November 01, 1972
Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorgan-specific autoimmune diseases. Ann Rheum Dis (1978) 1.05
Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis (1997) 1.05
Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol (1984) 1.02
Aging and the lacrimal system. Br J Ophthalmol (1997) 0.97
Morphological changes in the human conjunctival epithelium. II. In keratoconjunctivitis sicca. Br J Ophthalmol (1978) 0.93
Suppression of lymphocyte proliferation and regulation of dendritic cell phenotype by soluble mediators from rat lacrimal epithelial cells. Scand J Immunol (2009) 0.87
Morphological changes in the human conjunctival epithelium. I. In the normal elderly population. Br J Ophthalmol (1978) 0.87
Letter: Ocular reactions to beta-blocking drugs. Br Med J (1975) 0.85
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma. Case Rep Neurol Med (2014) 0.82
Sjogren's syndrome. Br Med J (1973) 0.75
Conjunctival mucoepithelial hyperplasia of the elderly. Int Ophthalmol (2015) 0.75
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science (1994) 11.22
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
Complexity, leadership, and management in healthcare organisations. BMJ (2001) 8.06
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med (1976) 7.00
Quality collaboratives: lessons from research. Qual Saf Health Care (2002) 6.78
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22
Method of obtaining optical sectioning by using structured light in a conventional microscope. Opt Lett (1997) 5.73
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing (1980) 4.30
Linkage analysis of quantitative traits: increased power by using selected samples. Am J Hum Genet (1991) 4.23
Systemic lupus erythematosus. Lancet (2001) 4.18
Evaluation of early diagnostic services for the elderly. Br Med J (1970) 4.00
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci U S A (1996) 3.60
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med (1980) 3.50
Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci (2000) 3.50
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. Br J Clin Pharmacol (1980) 3.28
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
A review of current literature on the impact of HIV/AIDS on children in sub-Saharan Africa. AIDS (2000) 3.23
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
An evaluation of home visiting of patients by physicians in geriatric medicine. Br Med J (Clin Res Ed) (1981) 3.04
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Promoting patient safety in primary care. BMJ (2001) 2.85
hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol Cell (1999) 2.85
Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br (2005) 2.71
Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science (1976) 2.70
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Old people and their relatives. Lancet (1966) 2.61
Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med (1974) 2.60
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
Interlaboratory comparison of ultrasonic backscatter, attenuation, and speed measurements. J Ultrasound Med (1999) 2.47
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med (1998) 2.45
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain. J Cell Biol (1998) 2.29
Method of sampling in a study of older people with a comparison of respondents and non-respondents. Br J Prev Soc Med (1971) 2.29
Linkage disequilibrium in domestic sheep. Genetics (2002) 2.29
Drug-induced parkinsonism in the elderly. Lancet (1984) 2.27
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med (1995) 2.20
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis (1978) 2.12
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Interaction of wild-type and mutant M protein vesicular stomatitis virus with nucleocapsids in vitro. Biochemistry (1981) 2.06
The changing face of ectopic pregnancy. BMJ (1997) 2.03
Hypothesis: that rheumatoid arthritis will disappear. J Rheumatol (1979) 2.01
Judging "current disease activity" in rheumatoid arthritis--an international comparison. J Rheumatol (1983) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Asymptomatic liver disease in hepatitis B antigen carriers. J Clin Pathol (1974) 2.00
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Chest injuries in a district general hospital. Ann R Coll Surg Engl (1982) 1.92
Telephone triage and consultation: an emerging role for nurses. Nurs Outlook (1999) 1.86
Acute synovial rupture of the knee--a differential diagnosis from deep vein thrombosis. Proc R Soc Med (1970) 1.85
Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83
A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA (2001) 1.82
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet (1999) 1.80
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80
Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (1973) 1.80
Size of the detector in confocal imaging systems. Opt Lett (1987) 1.79
Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut (2000) 1.78
Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol (1989) 1.77
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76